FDA Announces Voluntary Withdrawal of Pergolide Products FDA today announced
FDA Announces Voluntary Withdrawal of Pergolide Products
FDA today announced that manufacturers of pergolide drug products, which are used to treat Parkinson s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients heart valves.